Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–16 of 16 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT06445972
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +10 more
- Locations
-
- University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 8927) Tucson, Arizona, United States
- UCLA Hematology/Oncology - Santa Monica ( Site 8905) Los Angeles, California, United States
- Norton Cancer Institute - Downtown ( Site 8900) Louisville, Kentucky, United States
- The Cancer and Hematology Centers ( Site 8912) Grand Rapids, Michigan, United States
AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas
NCT07290985
- Conditions
- Gastroesophageal Adenocarcinoma
- Locations
-
- University of California, Los Angeles Los Angeles, California, United States
- Yale University New Haven, Connecticut, United States
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
- Conditions
- Adenocarcinoma, Adenocarcinoma Of Esophagus, Ampullary Adenocarcinoma, +13 more
- Locations
-
- Smilow Cancer Center New Haven, Connecticut, United States
NCT06529822
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
- Locations
-
- AdventHealth Orlando, Florida, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Ohio State University Columbus, Ohio, United States
NCT07069712
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastroesophageal Adenocarcinoma, +6 more
- Locations
-
- Research Site Newark, Delaware, United States
- Research Site Washington D.C., District of Columbia, United States
- Research Site Fairway, Kansas, United States
- Research Site North Shores, Michigan, United States
NCT07529808
- Conditions
- Adenocarcinoma, Advanced Gastric Cancer, CDH17-positive Advanced Solid Tumors, +32 more
- Locations
-
- NEXT Virginia Fairfax, Virginia, United States
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
NCT07544589
- Conditions
- Adenocarcinoma Of Esophagus, Adenoviridae Infections, Colonic Diseases, +17 more
- Locations
-
- City of Hope Duarte, California, United States
- University of Cincinnati Cancer Center Cincinnati, Ohio, United States
- Tennessee Oncology Nashville, Tennessee, United States
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +10 more
- Locations
-
- University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 6927) Tucson, Arizona, United States
- UCLA Hematology/Oncology - Santa Monica ( Site 6905) Los Angeles, California, United States
- Norton Hospital-Norton Cancer Institute - Downtown ( Site 6900) Louisville, Kentucky, United States
- The Cancer and Hematology Centers ( Site 6912) Grand Rapids, Michigan, United States
NCT05733689
- Conditions
- Gastroesophageal Adenocarcinoma
- Locations
-
- Chao Family Comprehensive Cancer Center, University Orange, California, United States
NCT03639714
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +25 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- Mayo Clinic Jacksonville, Florida, United States
- The University of Chicago Chicago, Illinois, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT03794128
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +25 more
- Locations
-
- University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
- Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center New York, United States
- The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- Tennessee Oncology Nashville, Tennessee, United States
Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma
NCT01757171
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Distal Esophageal Adenocarcinoma, +8 more
- Locations
-
- UCSF Comprehensive Cancer Center San Francisco, California, United States
- Yale University New Haven, Connecticut, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
NCT01045421
- Conditions
- Advanced Nonhematological Malignancies, Breast Diseases, Breast Neoplasms, +24 more
- Locations
-
- Houston, Texas, United States
- Salt Lake City, Utah, United States
Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer
NCT00073502
- Conditions
- Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma
- Locations
-
- University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States
- MD Anderson Cancer Center Houston, Texas, United States
- University of Utah, Huntsman Cancer Institute Salt Lake City, Utah, United States
- Dept Internal Medicine Gastrointestinal Oncology Unit B-3000 Leuven, Belgium
Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)
NCT04021108
- Conditions
- Gastroesophageal Adenocarcinoma
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Washington University School of Medicine St Louis, Missouri, United States
- University of Nebraska Omaha, Nebraska, United States
- Roswell Park Cancer Center Buffalo, New York, United States
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab
NCT05029882
- Conditions
- Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +20 more
- Locations
-
- University of California, Los Angeles /ID# 243841 Los Angeles, California, United States
- University Of Colorado Denver /ID# 231574 Aurora, Colorado, United States
- Yale School of Medicine /ID# 248418 New Haven, Connecticut, United States
- University of Illinois Hospital and Health Sciences System /ID# 251386 Chicago, Illinois, United States